These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33126419)

  • 1. YAP/TAZ Signalling in Colorectal Cancer: Lessons from Consensus Molecular Subtypes.
    Mouillet-Richard S; Laurent-Puig P
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33126419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
    Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
    BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
    Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer.
    Le Corre D; Ghazi A; Balogoun R; Pilati C; Aparicio T; Martin-Lannerée S; Marisa L; Djouadi F; Poindessous V; Crozet C; Emile JF; Mulot C; Le Malicot K; Boige V; Blons H; de Reynies A; Taieb J; Ghiringhelli F; Bennouna J; Launay JM; Laurent-Puig P; Mouillet-Richard S
    EBioMedicine; 2019 Aug; 46():94-104. PubMed ID: 31377347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms.
    Dobrokhotov O; Samsonov M; Sokabe M; Hirata H
    Clin Transl Med; 2018 Aug; 7(1):23. PubMed ID: 30101371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
    Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
    Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations.
    Yamaguchi H; Taouk GM
    Front Oncol; 2020; 10():928. PubMed ID: 32596154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
    Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
    Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
    Shreberk-Shaked M; Oren M
    Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology of YAP/TAZ: hippo signaling and beyond.
    Piccolo S; Dupont S; Cordenonsi M
    Physiol Rev; 2014 Oct; 94(4):1287-312. PubMed ID: 25287865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry.
    Azad T; Ghahremani M; Yang X
    Cells; 2019 May; 8(5):. PubMed ID: 31052445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis.
    Boopathy GTK; Hong W
    Front Cell Dev Biol; 2019; 7():49. PubMed ID: 31024911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Computational Model of YAP/TAZ Mechanosensing.
    Sun M; Spill F; Zaman MH
    Biophys J; 2016 Jun; 110(11):2540-2550. PubMed ID: 27276271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo signaling pathway provides novel anti-cancer drug targets.
    Bae JS; Kim SM; Lee H
    Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo Signaling in Cancer: Lessons From
    Snigdha K; Gangwani KS; Lapalikar GV; Singh A; Kango-Singh M
    Front Cell Dev Biol; 2019; 7():85. PubMed ID: 31231648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
    Noguchi S; Saito A; Nagase T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of YAP/TAZ activity in cancer metabolic reprogramming.
    Zhang X; Zhao H; Li Y; Xia D; Yang L; Ma Y; Li H
    Mol Cancer; 2018 Sep; 17(1):134. PubMed ID: 30176928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.
    Lo Sardo F; Strano S; Blandino G
    Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29734788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.